Skip to main content
. 2019 May 10;9:7242. doi: 10.1038/s41598-019-43673-x

Figure 6.

Figure 6

Working model of the therapeutic effects of CAY10594 against APAP-induced acute liver injury. CAY10594 blocks GSK-3β (Serine 9)/JNK phosphorylation in hepatocytes, eliciting therapeutic effects against APAP-induced acute liver injury model.